BMY
Bristol-Myers Squibb Company
Stock
$61.15−0.31 (−0.50%)Close Oct 2, 2026
Key figures
| Metric | Latest | 5-year CAGR |
|---|---|---|
| Revenue | $49.2B | +2.5% |
| Gross profit | $34.5B | +2.2% |
| Operating income | $1.4BQ1 2012 | — |
| Net income | $9.3B | — |
| EPS | $4.54 | — |
| Free cash flow | $11.4B | −0.7% |